Skip to main content
Caplight Logo









South Rampart Pharma, Inc.

South Rampart Pharma, Inc.

Private
New Orleans, LouisianaHealthcare & Life Scienceshttps://southrampartpharma.com/

Last Round

Series A

Apr 10, 2025

Total Funding Raised

$2.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

South Rampart Pharma, Inc. is a clinical-stage biopharmaceutical company that develops novel, non-opioid small molecule therapeutics designed to treat pain while avoiding the organ toxicity and addiction risks associated with current analgesics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

non-opioid analgesicpain managementbiotechnologydrug discoveryclinical-stage biotechsmall molecule drugnon-narcotic pain reliefclinical trialschronic pain treatmentneuropathic painbiopharmaopioid alternativepharmaceutical R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

South Rampart Pharma, Inc. Comparables

Compare South Rampart Pharma, Inc. with similar companies based on industry and business-model similarity.

South Rampart Pharma, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Latigo Biotherapeutics
87%
Akelos Inc.
84%
Eli Lilly and Company
81%

South Rampart Pharma, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 10, 2025
GrantSep 21, 2023
GrantSep 29, 2020

Key People

Founding team and executive leadership

Hernan Bazan

CEO, Co-founder

Founding Team

South Rampart Pharma, Inc. Investors

Notable investors and investment history

South Rampart Pharma, Inc. investors
InvestorRounds
Gulf South AngelsSeries A
NIH RADxGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 232% MoM, reaching 1.4K.

  • Jun 20, 2026

    Monthly visitors grew 147% MoM.

South Rampart Pharma, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

South Rampart Pharma, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about South Rampart Pharma, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Orleans, Louisiana
Employee Range5
Year Founded2017
Last FundingApr 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?